15.14
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.68%
139.16
|
134.22 | 121.98 | 114.80 | 117.55 |
| Cost Of Revenue |
14.08%
50.35
|
58.60 | 54.76 | 53.70 | 54.22 |
| Gross Profit |
17.44%
88.82
|
75.63 | 67.23 | 61.10 | 63.33 |
|
|
5.90%
26.07
|
24.61 | 24.43 | 26.22 | 25.01 |
| Benefits Costs and Expenses |
10.54%
77.57
|
86.71 | 81.89 | 81.35 | 82.84 |
| Costs And Expenses |
10.54%
77.57
|
86.71 | 81.89 | 81.35 | 82.84 |
| Depreciation and Amortization |
1.14%
2.046
|
2.023 | 2.058 | 1.969 | 1.944 |
| Operating Income/Loss |
23.01%
62.75
|
51.01 | 42.80 | 34.88 | 38.32 |
| Nonoperating Income/Loss |
66.94%
-1.156
|
-3.497 | -2.701 | -1.431 | -3.61 |
| Income/Loss From Continuing Operations Before Tax |
29.63%
61.59
|
47.52 | 40.10 | 33.45 | 34.71 |
| Income Tax Expense/Benefit, Deferred |
75.60%
1.172
|
4.803 | 1.62 | 3.425 | - |
| Income Tax Expense/Benefit |
10.18%
12.22
|
11.09 | 5.878 | 6.546 | -77.18 |
| Income/Loss From Continuing Operations After Tax |
35.55%
49.38
|
36.43 | 34.22 | 26.90 | 111.90 |
|
|
35.55%
49.38
|
36.43 | 34.22 | 26.90 | 111.90 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
100.05%
-0.109
|
238.60 | 241.49 | 237.78 | 1.1247 |
| Diluted Average Shares |
100.24%
-0.5867
|
244.66 | 248.61 | 244.68 | 1.5703 |
| Basic Earnings Per Share |
40.00%
0.21
|
0.15 | 0.14 | 0.11 | 0.48 |
| Diluted Earnings Per Share |
33.33%
0.20
|
0.15 | 0.14 | 0.11 | 0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):